The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Wattle Health Australia Limited has entered into a conditional purchase agreement with a subsidiary of Mason Holdings Limited.

Wattle Health Australia has purchase an extra 46 per cent of Australia’s largest independent nutritional dairy manufacturer, Blend and Pack (B&P), for A$46 million.

According to Wattle Health, funding for the Purchase Agreement will rely on a private placement debt issue, which will be managed by Exotix Capital.

Management presentations and investor site tours are scheduled to commence on the 19th April 2019. These events are expecting multiple parties to travel to Australia with intentions of finalising definitive terms soon after. 

Wattle Health is currently working on completing any and all conditions required to finalise the transaction.

This includes new shareholder agreements and a notice of meeting (NOM). Wattle Health expects the planned meeting date will be on the 13th June 2019, however, this may be extended to the 15th June 2019.

Please find the announcement attached

WHA by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…

BHP confirms £31.1B takeover bid for Anglo American

BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation…